(1S,3R,4S,5R)-3,5-Bis(((E)-3-(3,4-dihydroxyphenyl)acryloyl)-oxy)-1,4-dihydroxycyclohexanecarboxyl - Names and Identifiers
Name | Cyclohexanecarboxylicacid,3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,4-dihydroxy-,(1a,3R,4a,5R)-
|
Synonyms | 3, 5-O-Dicaffeoylquinic acid (-)-3,5-Dicaffeoyl quinicacid 3,5-Di-O-caffeoyl quinic acid (-)-3,5-Dicaffeoyl quinic acid (E,E)-3,5-Dicaffeoylquinic acid (E,E)-3,5-Di-O-caffeoylquinic acid (1S,3R,4S,5R)-3,5-Bis(((E)-3-(3,4-dihydroxyphenyl)acryloyl)-oxy)-1,4-dihydroxycyclohexanecarboxyl (1S,3R,4S,5R)-3,5-Bis(((E)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)-1,4-dihydroxycyclohexanecarboxylic acid (3R,5R)-3,5-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1,4-dihydroxycyclohexane-1-carboxylic acid Cyclohexanecarboxylicacid, 3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4-dihydroxy-,(1a,3R,4a,5R)- Cyclohexanecarboxylicacid,3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,4-dihydroxy-,(1a,3R,4a,5R)- Cyclohexanecarboxylic acid, 3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,4-dihydroxy-, (1α,3R,4α,5R)- Cyclohexanecarboxylic acid,3,5-bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4-dihydroxy-, [1R-[1a,3a(E),4a,5b(E)]]-
|
CAS | 89919-62-0
|
(1S,3R,4S,5R)-3,5-Bis(((E)-3-(3,4-dihydroxyphenyl)acryloyl)-oxy)-1,4-dihydroxycyclohexanecarboxyl - Physico-chemical Properties
Molecular Formula | C25H24O12
|
Molar Mass | 516.46 |
Density | 1.64 |
Boling Point | 826.2±65.0 °C(Predicted) |
pKa | 3.52±0.50(Predicted) |
Storage Condition | 2-8°C |
(1S,3R,4S,5R)-3,5-Bis(((E)-3-(3,4-dihydroxyphenyl)acryloyl)-oxy)-1,4-dihydroxycyclohexanecarboxyl - Introduction
Cyclohexanecarboxylicacid,3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,4-dihydroxy-,(1a,3R,4a,5R)-, chemical name is Cyclohexanecarboxylicacid,3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-3-1-hydroxyphenyl, 2-hydroxy-R, 4-hydroxy-4a, 5R)-is an organic compound with a special structure.
The properties of the substance include:
-Appearance: Usually white to yellow crystalline solid
-Solubility: Soluble in many organic solvents, such as ethanol, dimethylformamide
-melting point: about 166-168 ℃
-Molecular weight: about 596.52g/mol
Cyclohexanecarboxylicacid,3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,4-dihydroxy-,(1a,3R,4a,5R)-is primarily used as a medicament. It has antioxidant, anti-inflammatory and antibacterial activities, so it is often used in the field of medicine. The substance is commonly used to study the biological activity of quinic acid derivatives and can be used as an antioxidant additive for natural products.
Cyclohexanecarboxylicacid,3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,4-dihydroxy-,(1a,3R,4a,5R)-is prepared mainly by extraction from natural sources or by chemical synthesis. When extracted from natural sources, plant materials containing quinic acid, such as coffee beans or tea leaves, are often used and subjected to appropriate treatment and purification processes. Chemical synthesis methods are diverse, but more complex, and generally require continuous reaction steps to obtain the target product.
Regarding safety information, Cyclohexanecarboxylicacid,3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,4-dihydroxy-,(1a,3R,4a,5R)-has low toxicity and harmfulness. However, as a chemical substance, the following points still need to be paid attention to when using and handling:
-Avoid contact with skin and eyes to prevent allergies or irritation
-When using or handling, maintain good ventilation conditions
-If swallowed or touched accidentally, seek medical help immediately and bring the product label
-Please follow the correct experimental procedures and personal protective measures when using
In summary, Cyclohexanecarboxylicacid,3,5-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1,4-dihydroxy-,(1a,3R,4a,5R)-is an important drug with antioxidant and biological activity. It is obtained by extraction from natural sources or by chemical synthesis. Pay attention to relevant safety information when using and handling.
Last Update:2024-04-09 20:02:46